Molecular strategies targeting the host component of cancer to enhance tumor response to radiation therapy

Dong Wook Kim, Jessica Huamani, Allie Fu, Dennis E. Hallahan

Research output: Contribution to journalArticlepeer-review

41 Scopus citations

Abstract

The tumor microenvironment, in particular, the tumor vasculature, as an important target for the cytotoxic effects of radiation therapy is an established paradigm for cancer therapy. We review the evidence that the phosphoinositide 3-kinase (PI3K)/Akt pathway is activated in endothelial cells exposed to ionizing radiation (IR) and is a molecular target for the development of novel radiation sensitizing agents. On the basis of this premise, several promising preclinical studies that targeted the inhibition of the PI3K/Akt activation as a potential method of sensitizing the tumor vasculature to the cytotoxic effects of IR have been conducted. An innovative strategy to guide cytotoxic therapy in tumors treated with radiation and PI3K/Akt inhibitors is presented. The evidence supports a need for further investigation of combined-modality therapy that involves radiation therapy and inhibitors of PI3K/Akt pathway as a promising strategy for improving the treatment of patients with cancer.

Original languageEnglish (US)
Pages (from-to)38-46
Number of pages9
JournalInternational Journal of Radiation Oncology Biology Physics
Volume64
Issue number1
DOIs
StatePublished - Jan 1 2006

Keywords

  • Akt
  • Combined modality therapy
  • Endothelium
  • Radiation sensitizer
  • Vasculature targeted therapy

ASJC Scopus subject areas

  • Radiation
  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Fingerprint Dive into the research topics of 'Molecular strategies targeting the host component of cancer to enhance tumor response to radiation therapy'. Together they form a unique fingerprint.

Cite this